Covered recipient · General Payments record
KARA LOMSKI
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$1,232.15
- Reported across 62 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $568.89 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABIOMED | $106.52 | 1 |
| Novo Nordisk AS | $100.09 | 6 |
| PFIZER INC. | $69.23 | 4 |
| Agios Pharmaceuticals, Inc. | $60.81 | 3 |
| Lundbeck LLC | $55.55 | 2 |
| Lilly USA, LLC | $51.01 | 3 |
| ABBVIE INC. | $43.89 | 3 |
| Merck Sharp & Dohme Corporation | $25.67 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.31 | 1 |
| Nevro Corp. | $18.52 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.96 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107551455 | CMS |
| ABBVIE INC. | $14.56 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107551457 | CMS |
| ABBVIE INC. | $13.37 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107551459 | CMS |
| ABIOMED | $106.52 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142209816 | CMS |
| Agios Pharmaceuticals, Inc. | $20.27 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149641726 | CMS |
| Agios Pharmaceuticals, Inc. | $20.27 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149644803 | CMS |
| Agios Pharmaceuticals, Inc. | $20.27 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149646420 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.31 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118078398 | CMS |
| Lilly USA, LLC | $17.05 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135725889 | CMS |
| Lilly USA, LLC | $15.17 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135731040 | CMS |
| Lilly USA, LLC | $18.79 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135731042 | CMS |
| Lundbeck LLC | $22.70 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146052545 | CMS |
| Lundbeck LLC | $32.85 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146052547 | CMS |
| Merck Sharp & Dohme LLC | $25.67 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141799471 | CMS |
| Nevro Corp. | $18.52 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130782230 | CMS |
| Novartis Pharmaceuticals Corporation | $16.29 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087037880 | CMS |
| Novo Nordisk Inc | $15.01 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100639546 | CMS |
| Novo Nordisk Inc | $23.13 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100231142 | CMS |
| Novo Nordisk Inc | $15.73 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100394198 | CMS |
| Novo Nordisk Inc | $18.43 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100248760 | CMS |
| Novo Nordisk Inc | $13.48 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100380163 | CMS |
| Novo Nordisk Inc | $14.31 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100583962 | CMS |
| PFIZER INC. | $21.96 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131516637 | CMS |
| PFIZER INC. | $15.79 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131525623 | CMS |
| PFIZER INC. | $15.41 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131575427 | CMS |
| PFIZER INC. | $16.07 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131511492 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.